| 2025 | 2024 | 2023 | 2022 | 2021 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 158,4 k € | -75.0% | 635,0 k € | +898.7% | -79,5 k € | +54.9% | -176,3 k € | +35.1% | -271,7 k € | |
| EBITDA | 158,0 k € | -75.1% | 634,5 k € | +644.2% | -116,6 k € | +48.9% | -228,4 k € | +16.8% | -274,6 k € | |
| Operating profit | 7,1 k € | -98.7% | 545,1 k € | +387.8% | -189,4 k € | +31.3% | -275,9 k € | +2.9% | -284,0 k € | |
| Profit/loss | 14,1 k € | -97.4% | 533,6 k € | +381.0% | -189,9 k € | +14.1% | -221,0 k € | +3.2% | -228,2 k € | |
| Equity | 579,0 k € | +2.5% | 564,8 k € | +394.6% | -191,7 k € | -10392.5% | -1,8 k € | -100.7% | 267,8 k € | |
| Total assets | 1,0 M € | +0.2% | 1,0 M € | +232.5% | 310,6 k € | +5.7% | 293,9 k € | -45.4% | 538,0 k € | |
| Cash | 19,1 k € | -88.5% | 166,6 k € | +18376.0% | 901,7 € | -93.5% | 13,8 k € | -96.5% | 399,6 k € | |
| Debts | 455,6 k € | -2.6% | 467,9 k € | -6.8% | 502,3 k € | +69.9% | 295,7 k € | +9.4% | 270,2 k € | |
Private limited company · La Hulpe · incorporated on 25/09/2020
Private limited company profitable and well capitalised. Cash position declining (-88.5%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
OLYS Pharma is a Private limited company incorporated in 2020. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in La Hulpe.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette